
Blog | News
Heart Failure Universal Academy | 1ST Edition
Milano Novotel Ca’ Granda | 8/9 Maggio 2025
read and comment the articleMar
Blog | European Journal of Heart Failure
π₯ QoL (Quality of Life) in HeartFailure.
The heart of the matter. A scientific statement of the hashtag#HFA and the hashtag#EAPC of the European Society of Cardiology
read and comment the articleMar
Blog | European Journal of Heart Failure
π₯ EMPULSE subanalysis
π Another proof of safety & efficacy of SGLT2i in AHF with Low BP π‘ A further confirmation of the Smart effect on Blood Pressure
read and comment the articleMar
Blog | European Journal of Heart Failure
π₯ IRONMAN trial : 1st study that show no risk of infection after IV ferrum in HFrEF
β No deathβ οΈ of hospitalizations π₯ due to infection after iron
read and comment the articleMar
Blog | European Journal of Heart Failure
π₯ VICTOR trial : baseline characteristics of enrolled populations compared to other RCTs in HFrEF
β Will be Vericiguat the 5th pillar in HFrEF? π― The aim is to complete the spectrum partially covered by VICTORIA beyond WorseningHF in HFrEF
read and comment the articleFeb
Blog | European Journal of Heart Failure
π₯ Silencers vs stabilizers in TTR amyloid cardiomyopathy
Are we asking the wrong questions? π¬ Not a great difference between the 2 classes In several cases the disease keeps progressing 𧨠β Waiting for amyloid removers π Long & winding road to the understanding of amyloidosis pathophysiology π€ Fibrosis & collagen production significant part of the process β Why someone develops wild-type ATTR ( or SSA) & others...
read and comment the articleFeb
Blog | European Journal of Heart Failure
π₯ Beta_blockers in HFmrEF & HFpEF >16000 pts
β Association with β¬οΈ CV β οΈ & HHF π₯ in both groups β³οΈ Be careful to chronotropic incompetence
read and comment the articleFeb
Blog | European Journal of Heart Failure
π₯ FAIR_HF2 : High dose IV FerricCarboxymaltose in iron deficiency & HFrEF to reduce morbidity & mortality
π Rationale & Design
read and comment the articleFeb
Blog | European Journal of Heart Failure
π₯ ποΈ CANVAS & CREDENCE pooled analysis
Another proof of diuretic effect of SGLT2i
read and comment the articleJan
Blog | European Journal of Heart Failure
π₯ FIDELITY subanalysis: Finerenone efficacy & Safety in CKD & T2DM, by diuretic use ~ 13.000 pts
No difference with or without diuretics about: Cardiovascular Death β οΈ + HF hospitalization π₯Kidney outcomes ππ»
read and comment the articleJan
Blog | European Journal of Heart Failure
π₯ SUGAR_DM_HF: CardiovascularMagneticResonance estimated Pulmonary CapillaryWedge Pressure & congestion markers, & effect of empagliflozin in HFrEF in pre_diabets & T2DM
β‘οΈ A new tool of CMR that can provide another evolution for multimodality imaging in HeartFailure
read and comment the articleJan
Blog | European Journal of Heart Failure
HappyNewYear Linkedin CardioVascularCommunity by the HeartFailureUniversalAcademy. HFUA
Letβs start 2025 with a hot HeartFailure topic π₯ Prediction of HF Events in DCM & HFmrEF using multiparametric CMR
read and comment the articleJan
Blog | European Journal of Heart Failure
π₯ EVOLUTION : Observational study for multiparametric assessment of cardiac congestion in outpatient worsening HF (WHF)
Role of NTproBNP , TnHS , CystatinC
read and comment the articleJan
Blog | European Journal of Heart Failure
π₯ Machine learning approach to identify phenotypes in patients with ischaemic HFrEF
HFUA HeartFailureUniversalAcademy It will be the future of phenotyping?
read and comment the articleDec
Blog | European Journal of Heart Failure
π₯Outpatient WorseningHF & mortality in transthyretin cardiomyopathy
πOral diuretic intensification (ODI) predicts mortality β οΈ as HeartFailure Hospitalizations π₯ π This in ATTR_CMP on treatment with tafamidis
read and comment the articleDec
Blog | European Journal of Internal Medicine
π₯ Our observational study based on data of Regione Lombardia on more than 10 millions people showed a significant association between HeartFailure & Non_Cardiac_Comorbidites
A mean of 42 months of follow-up (2015-2019) β More comorbidities associated with All_cause_deathβ οΈ and β¬οΈ rate of re-hospitalizations π₯ β The higher the n^ of comorbidities the longer the length of hospitalization πΉπΊ Same data for both sexes βοΈ HF pts with 4 or more non cardiac comorbidities had a mean length of hospitalization of 45 days
read and comment the articleDec
Blog | Roche
Il cuore Γ¨ un organo endocrino che produce i peptidi natriuretici in risposta allo stress di parete che si genera nello scompenso cardiaco.
Il cuore Γ¨ un organo endocrino che produce i peptidi natriuretici in risposta allo stress di parete che si genera nello scompenso cardiaco. Lβormone principale con effetti sistemici Γ¨ il BNP, che viene prodotto come pro-ormone e poi scisso porzione attiva BNP e in quella non attiva NTproBNP. Il sistema dei peptidinatriuretici Γ¨ il principale sistema neuro-ormonale che antagonizza gli...
read and comment the articleDec
Blog | European Journal of Heart Failure
π₯DREAM_HF : Mesenchymal precursor cells β¬οΈ β οΈ & major morbidity in ischemic HeartFailure with inflammation
π A new hope beyond traditional pharmacological & devices therapy
read and comment the articleDec
Blog | European Journal of Heart Failure
π₯ Gene 𧬠therapy in HeartFailure : HFA , European Society of Cardiology Council on CV genomics & WG Myocardial & Pericardial Diseases Scientific Statement
β‘οΈ State of art and future perspectivesπ Amyloidosis new therapiesπππ Dilated, Hypertrophic,Restrictive and Arrhythmogenic Cardiomyopathiesπ§ Hypercolesterolemia
read and comment the articleNov
Blog | European Journal of Heart Failure
π₯ Water & Salt Balance in HF
π Not only sodium & salt π§ , but the majority is water π§
read and comment the articleNov
Blog | European Journal of Heart Failure
π₯ Cardiovascular toxicities of immunotherapy for cancer π β οΈ
π Incidence, Pathophysiology & Management of AdverseEvent by HFA & CardioOncology Council European Society of Cardiology
read and comment the articleNov
Blog | Roche
Lo Scompenso Cardiaco colpisce piΓΉ di 1 milione di persone in Italia, Γ¨ la 1Βͺ causa di ospedalizzazione al mondo ed Γ¨ gravato da un alto tasso di mortalitΓ – piΓΉ alto di molti cancri – e di re-ospedalizzazione. β οΈ π₯
I sintomi sono spesso aspecifici e in 1 un paziente su 3 portano a diagnosi errate. In generale lo Scompenso Cardiaco rimane largamente sottodiagnosticato, infatti circa lβ80% dei pazienti riceve la diagnosi a seguito di un ricovero per Scompenso Cardiaco Acuto. π¨ Questo espone i pazienti ad un rischio incrementale di morte del 28% rispetto ad un paziente che riceve...
read and comment the articleNov
Blog | European Journal of Heart Failure
π₯ VICTOR trial design : Vericiguat in Chronic HFrEF
Will be vericiguat ready to be the 5th pharmacological pillar in HFrEF ? HFUA HeartFailureUniversalAcademy
read and comment the articleNov
Blog | European Journal of Heart Failure
π₯ The 25in25 initiative : A novel project to reduce HF β οΈ 25% in the next 25 y
HFprevalence is still alarmingly raising π¨ Detect the undetected & treat it π HFUA
read and comment the articleOct
Blog | European Journal of Heart Failure
π₯ Microvascular obstruction (MVO) in amyloidosis
MVO is associated with an β¬οΈ risk of β οΈ in AL but not in ATTR β This reflects the intrinsic differences between these 2 forms of CA π The toxic effect of light chain amyloidosis. AL . One of the cultural legacies of Prof Rapezziπ‘ π
read and comment the articleOct
Blog | European Journal of Heart Failure
π₯ FOREST_HCM : Aficamtem in Non-Obstructive HCM (HNOCM)
β¬οΈ Symptoms (NYHA) QoL (KCCQ) β¬οΈ TnI & NTproBNP π Safe with mild β¬οΈ of LVEF π A new treatment for HNOCM is coming
read and comment the articleOct
Blog | Minerva Cardiology Angiology
π₯ Our article dedicated to a new predictive score in extrasystolic arrhythmia : βEX-prognosisβ
A beautiful idea of Olga Germanova Thanks to all the authors Giuseppe Biondi Zoccai Minerva Cardiology Angiology
read and comment the articleOct
Blog | European Journal of Heart Failure
π₯ Diabetic myocardial disorder
A new statement of HFA & European Society of Cardiology WG on Myocardial & Pericardial Diseases A complex interplay in the CardioRenalMetabolic axis
read and comment the articleOct
Blog | World Heart Day
World Heart Day
Cardiovascular Diseases are the 1st cause of β οΈ and HeartFailure is the 1st cause of hospitalization globally π ! Letβs fight them together ! ProtectΒ Heart β€οΈ π« Cardiovascular Diseases produced a cost only in the European Union and only for 2021 of 282 billions of euros πΆ π₯
read and comment the articleSep
Blog | European Journal of Heart Failure
π₯ Association of Multiple Non HCM & outcomes in HCM
A new study on multiple mutations & poor outcomes in HCM 𧬠See our recent editorial βThe Role of Multiple Mutations in HCM β A New Universe to discover π₯ Multiple mutations in HCM are associated with End_Stage or Hypokinetic & Dilated evolution & with HF & arrhythmia development
read and comment the articleSep
Blog | European Journal of Heart Failure
π₯ Aetiology & Clinical manifestations of NDLVC
π Genetic a prevalent causeπ¬ Myocarditis can uncover a genetic CMPπ« NDLVC a starting disease phenotype
read and comment the articleSep
Blog | European Journal of Heart Failure
π₯ HF risk assessment in HCM based on the H2FPEF score
Risk prediction in both HOCM & HNOCM HCM a cause not a βmimicβ of HFpEF
read and comment the articleSep
Blog | European Journal of Heart Failure
π₯ DECISION A new RCT on low dose digoxin in HF with LVEF < 50% both sinus rhythm & AF
Will be the last trial on the topic? Maybe we will obtain a final answer π
read and comment the articleSep
Blog | European Journal of Heart Failure
π₯ EXPAND: A real life study that confirms that the major driver of benefits of MitraClip in FMR & HFrEF
EXPAND a study that shows the same results of a fresh meta-analysis which included COAPT MITRA_FR & RESHAPE_HF2 > more than 800 pts With due differences among populations but for the same disease
read and comment the articleSep
Blog | The new england journal of medicine
π₯β€οΈβπ₯FINEARTS_HF. FineHearts_HF
Finerenone confirmed a 16% RRR of CV β οΈ & Total HHF π₯ A 2nd pillar for HFmrEF & HFpEF has just been built ποΈ The need of new #2025 HFguidelines is now urgent!
read and comment the articleSep
Blog | The new england journal of medicine
π₯ RESHAPE_HF2 NEJM Confirmed an important role of MitraClip in FMR & HFrEF
Similar effects of ARNI & SGLT2i RESHAPE_HF unveiled the grey part of the major benefit of MITRA_Clip is HHF Intermediate characteristics between MITRA_FR & COAPT & intermediate results between the 2 trials Drug & devices similar effects in HFrEF
read and comment the articleAug
Blog | European Journal of Heart Failure
π₯ Implementation of GDMT for HeartFailure : Progress achieved, work ahead !
ποΈββοΈ Still a lot of job to do to implement GDMT HF β οΈ still not significantly changed due to poor use of new therapies!
read and comment the articleAug
Blog | European Journal of Heart Failure
π₯ NATRIUM_HF: Congestion & β¬οΈ response to fluid/Na+ challenge in HFrEF after ARNI initiation
β Another proof of diuretic, natriuretic & Weight β¬οΈ effect of ARNI
read and comment the articleAug
Blog | European Journal of Heart Failure
π₯ Mechanisms of myocardial Reverse Remodeling: statement of European Society of Cardiology WG on myocardial function
From stressors, physiopathological models, therapeutic effects of drugs & devices & new treatments
read and comment the articleAug
Blog | European Journal of Heart Failure
π₯ ποΈ VICTORIA echocardiography substudy:
β¬οΈ of biomarkers related to inflammation & cardiac metabolism (TNF_R1 & PRTN3) associated with reverse remodeling in HFrEF
read and comment the articleAug
Blog | European Journal of Heart Failure
π₯ Updated Quality indicators for the care & outcomes of HeartFailure
Congrats to European Society of Cardiology hashtag#HFA Priv.-Doz. Dr. Amr Abdin for the eye-catching & instantly understable paper
read and comment the articleAug
Blog | European Journal of Heart Failure
π₯ Change in 6mwt is an independent predictor of all-cause death in HFrEF
Discover the simple & easy to use 6mwt in HFrEF a predictor of β οΈ independent of: NYHA NTproBNP
read and comment the articleJul
Blog | European Journal of Heart Failure
π₯ RESHAPE_HF2 High time to discover the grey part between the white (COAPT) & black side (MITRA_FR) of the moon π
MitraClip in FMR & HFrEF π Intermediate characteristics between COAPT & MITRA_FR π β¬οΈ % of ARNI & STLT2i use πResults soon at ESCCongress
read and comment the articleJul
Blog | European Journal of Heart Failure
π₯ Updated Quality indicators for the care & outcomes of HeartFailure
Congrats to European Society of Cardiology hashtag#HFA Priv.-Doz. Dr. Amr Abdin for the eye-catching & instantly understable paper
read and comment the articleJul
Blog | European Journal of Heart Failure
π₯ FINEHEARTS_HF
πDiscover the characteristics of HF population enrolled.The new kid on the block in HF & CardioRenalMetobolic area is coming soon at ESCCongress Finererone a new MRAHFUAEJHF π π 36% HFmrEFπ 45% HFpEF (EF:50-60%)π19% HFpEF>60%
read and comment the articleJul
Blog | European Journal of Heart Failure
πA pleasure to collaborate again with the EJHF & European Society of Cardiology with Priv.-Doz. Dr. Amr Abdin & Han Naung Tun
Thank to Prof BΓΆhm the Editor in Chief of the hashtag#EJHF for the invitation The best is yet to come π
read and comment the articleJul
Blog | European Journal of Heart Failure
π₯ Our new editorial on Cardiology π
βThe Role of Multiple Mutations in HCM – A New Universe to Discover:Proof of Guiltiness of the Genetic Burden in Worsening Hypertrophic Cardiomyopathy Natural History π¬ 𧬠Discover the role of multiple mutations & especially of calcium channels gene + sarcomeric mutations in HCM through our last editorial on Cardiology
read and comment the articleJun